Aromatase Inhibitors and Antiepileptic Drugs: A Study on Similarities
Author Information
Author(s): Muftuoglu Yagmur, Mustata Gabriela
Primary Institution: Johns Hopkins University
Hypothesis
Can a pharmacophore model designed for aromatase inhibitors identify antiepileptic drugs?
Conclusion
The study found that many antiepileptic drugs share significant chemical and structural similarities with aromatase inhibitors, suggesting potential for new treatment options.
Supporting Evidence
- 73% of antiepileptic drugs were identified by the pharmacophore model.
- 82% of compounds with anticonvulsant properties matched the model.
- The model successfully identified seven compounds with both anticonvulsant and aromatase-inhibiting effects.
Takeaway
This study shows that some medicines for epilepsy are similar to those used for breast cancer, which might help find better treatments for seizures.
Methodology
The study used a pharmacophore model to screen FDA-approved drugs for similarities with known aromatase inhibitors.
Potential Biases
The pharmacophore model may not account for all structural variations among drugs.
Limitations
The study primarily focused on FDA-approved drugs and may not encompass all potential candidates.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website